Medical Xpress - An affordable hepatitis C combination treatment including the new drug candidate ravidasvir has been shown to be safe and effective, with extremely high cure rates for patients, including hard-to-treat cases, according to interim results from the Phase II/III STORM-C-1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris. "The results indicate that the sofosbuvir/ravidasvir combination is comparable to the very best...>>>
Nessun commento:
Posta un commento